Atlas Trials

Stage IV Prostate Adenocarcinoma AJCC v7

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Prostate Adenocarcinoma AJCC v7

RecordFirmDate
Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer (NCT03503344)University of California, San Francisco2019-12-17
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency (NCT03442556)University of Washington2018-08-24
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial (NCT03371719)NRG Oncology2018-06-20
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer (NCT03406858)Barbara Ann Karmanos Cancer Institute2018-06-07
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer (NCT03456843)Yale University2018-03-20
ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer (NCT03456804)Barbara Ann Karmanos Cancer Institute2018-03-08
Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer (NCT02893917)National Cancer Institute (NCI)2017-08-11
A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy (NCT02849990)University of Washington2017-03-09
Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02703623)M.D. Anderson Cancer Center2016-05-18
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer (NCT02215161)University of California, San Francisco2014-09-02
Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy (NCT02099864)OHSU Knight Cancer Institute2014-02-05
Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis (NCT01409200)M.D. Anderson Cancer Center2012-03-26
Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer (NCT00544830)City of Hope Medical Center2006-07-18

Track Stage IV Prostate Adenocarcinoma AJCC v7 automatically

Every clearance here is in the API, with alerts when new ones post.